发明名称 4'-FLUORO NUCLOSIDES FOR THE TREATMENT OF HCV
摘要 Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, the compounds are according to Formula 1501:;;or a pharmaceutically acceptable salt, solvate, stereoisomeric form, tautomeric form or polymorphic form thereof, wherein B, PD, RA, RB, RC, L, M and Z are as described herein.
申请公布号 US2014178338(A1) 申请公布日期 2014.06.26
申请号 US201314109463 申请日期 2013.12.17
申请人 IDENIX PHARMACEUTICALS, INC. ;UNIVERSITÉ MONTPELLIER 2 SCIENCES ET TECHNIQUES ;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 发明人 MAYES Benjamin Alexander;MOUSSA Adel M.;STEWART Alistair James;GOSSELIN Gilles
分类号 A61K31/708;A61K31/7072;A61K45/06;C07H17/02 主分类号 A61K31/708
代理机构 代理人
主权项 1. A compound according to Formula 1501:or a pharmaceutically acceptable salt, solvate, stereoisomeric form, tautomeric form, or polymorphic form thereof, wherein: B is a nucleobase; PD is W is S or O; each of X and Y is independently hydrogen, —OR1, —NR1R2, Of an N-linked or O-linked amino acid residue or an N-linked or O-linked residue of an amino acid derivative; Z is —H or —OH; or, in the alternative, X and Z, together with the atoms to which they are attached, combine to form a six-membered heterocyclic ring wherein X and Z together represent a single divalent —O—; and Y is hydrogen, —OR1, —NR1R2, an N-linked or O-linked amino acid residue or an N-linked or O-linked residue of an amino acid derivative; each of RA and RB is independently hydrogen, hydroxyl, alkyl, halo, cyano, azide, alkoxyl, or thiol; or, in the alternative, RA and RB, together with the atoms to which they are attached, combine to form a 3-10 membered carbocyclic or heterocyclic ring; RC is hydrogen or alkyl; L is —O— or —CH2—; M is —CH2—, —O— or —S—; R1 at each occurrence is independently hydrogen, alkyl, cycloalkyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; and R2 at each occurrence is independently hydrogen or alkyl; provided that when B is uracil; Z and RA are each hydroxyl; L and M are each —O—; RB is methyl; and RC is hydrogen, then PD is other thanand provided that when B is uracil or cytosine; Z and RA are each hydroxyl; L and M are each —O—; and RB and RC are hydrogen, then PD is other than
地址 CAMBRIDGE MA US